Polio cases are down 99.9% since 1988, but the #COVID19 pandemic has set back vaccinations and placed this incredible progress at risk. Let's strengthen our efforts to #EndPolio and ensure that progress against this virus is not lost.
In 2020, after 4⃣ years without a case, @WHOAFRO has been certified as wild polio-free!
On this #WorldPolioDay, take a moment to learn about remarkable success against wild #polio in Africa.
#Polio is a highly infectious viral disease.
It’s transmitted from person-to-person mainly through the faecal-oral route or via contaminated water or food. It can invade the nervous system & cause paralysis.
The 8 November #polio campaign in Afghanistan - the first national house-to-house campaign in over 3 years - will be followed by a second campaign, to be synchronized with Pakistan in December.
In many communities around the 🌍, women health workers help navigate social, cultural religious and political contexts to engage with communities. The #polio program’s strategy will continue supporting the women who are central in the fight to #EndPolio.
#Polio workers leave a purple mark on the pinky finger of children they vaccinate. They also leave their mark on the 🌍 by providing other needed services like clean water, nutrition supplements, bed nets and much more. #EndPolio
Alongside their work to #EndPolio, polio workers:
✅Help distribute #COVID19 vaccines
✅Conduct surveillance for multiple diseases
✅Respond to health emergencies
In countries that are #polio-free, we help people repurpose these skills to improve a range of health outcomes!
The work of the #polio program doesn’t stop with a vaccine. The infrastructure created to #EndPolio around the world is being used every day to:
🏙️ promote cleaner, safer communities
🛡️ fight other diseases
🔨 build a healthier future to achieve #HealthForAll
We have come so far in the fight against polio thanks to the leadership of countless #polio champions. A polio-free 🌎🌍🌏 is possible, but only with the continued commitment from all levels of government.
WHO published its Management Response Plan to address the findings of the Independent Commission on allegations of sexual abuse and exploitation during the 10th #Ebola outbreak response in #DRC ⬇️ bit.ly/3m2cWGO
The plan outlines short-term actions focusing on the most urgent Commission's recommendations, but also describes the actions that WHO will undertake over the next 15 months to improve its policies and procedures. bit.ly/3CcnSHO
WHO is committed to supporting the survivors of sexual abuse and exploitation in #DRC including with livelihood support. bit.ly/3CcnSHO
We need political leaders and policymakers to do all they can to make regulatory, policy and investment decisions that ensure the protection of 👩⚕️👨⚕️
@DrTedros "I have often said that universal health coverage and health security are two sides of the same coin. Both depend on health systems that are resilient, efficient and effective, and able to surge to respond to emergencies"-@DrTedros#HealthForAll
@DrTedros "Health systems like that are a vital first line of defence against outbreaks with epidemic and pandemic potential; but they’re also essential for promoting health, preventing communicable and noncommunicable diseases, and for reducing inequalities and inequities"-@DrTedros
#COVID19 has shown that there can be no lasting economic development without #HealthForAll & protection against health emergencies. Here are WHO’s 7⃣ recommendations on building resilient health systems based on #PrimaryHealthCare & #HealthSecurity.
1️⃣ We must leverage the #COVID19 response to strengthen pandemic preparedness & health systems. While tackling the pandemic, countries can also build long-term capacities to manage emergency risks & maintain essential health services.
We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective.
Bharat Biotech - the manufacturer of Covaxin - has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data.
WHO is expecting one additional piece of information from the company today.
The timeframe for the WHO Emergency Use Listing procedure is dependent on how quickly a company producing the vaccine is able to provide the data required for WHO to evaluate the vaccine’s quality, safety, efficacy and its suitability for low- and middle-income countries.